FDA Now Requiring New Warnings For Prescription Opioids
Drug Topics
APRIL 24, 2023
The FDA is hoping these warnings are a positive step in what will be an extremely long process of ending opioid related deaths.
Drug Topics
APRIL 24, 2023
The FDA is hoping these warnings are a positive step in what will be an extremely long process of ending opioid related deaths.
Drug Topics
APRIL 27, 2023
How much does education about the specific risks of smoking assist in smoking cessation?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
APRIL 25, 2023
As the overdose crisis rages on and the pandemic-fatigued public runs low on empathy, there have been increasing calls for expanded involuntary commitment for people with substance use disorder. Some of the advocacy for more coercive treatment seems rooted in a disdain for people who use drugs, most especially when their drug use occurs visibly and in close geographic proximity to affluence, for example in San Francisco or in the Massachusetts Avenue and Melnea Cass area of Boston which borders
PhRMA
APRIL 28, 2023
Today, the House Energy & Commerce Subcommittee on Oversight and Investigations will be holding a hearing on the growing public health threat of antimicrobial resistance (AMR). AMR occurs when microorganisms such as bacteria, viruses, fungi and parasites develop the ability to survive against the drugs designed to kill them. Recognized by the World Health Organization (WHO) as “one of the biggest threats to global health, food security and development today,” AMR is a growing crisis that has
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaVoice
APRIL 25, 2023
The longtime pharma leader is stepping down from his role as chair of Regeneron’s board in June after decades in drug development.
Drug Topics
APRIL 28, 2023
The drug treats amyotrophic lateral sclerosis (ALS) associated with a mutation in the superoxide dismutase 1 (SOD1) gene (SOD1-ALS).
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PhRMA
APRIL 25, 2023
There is increasing talk about making changes to our health care system to lower costs for patients and address misaligned incentives. These are important conversations that could lead to meaningful improvements, but only if policymakers take a holistic approach to address all the health care drivers. Far too often, there is a singular focus on prescription medicines, ignoring the other parts of the supply chain that are key drivers of U.S. health care spending.
PharmaVoice
APRIL 28, 2023
An industry veteran, innovator and curator, Dr. Amir Kalali’s vision for the future is patient-focused.
Drug Topics
APRIL 27, 2023
Insulet plans to commercialize the new product in the United States starting in 2024.
Pharmacy Times
APRIL 25, 2023
The FDA considers alcohol hangover as a disease, requiring treatments to be registered as drugs.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PhRMA
APRIL 26, 2023
Today PhRMA joins with innovators around the globe to recognize World IP Day and celebrate biopharmaceutical innovators who dedicate their lives to bringing new treatments and cures to patients. It’s also a day to reflect on the role Intellectual Property (IP) protections, such as patents, play in supporting the development of cutting-edge technologies.
PharmaVoice
APRIL 24, 2023
Dr. Preeti Parikh sees parallels between promoting health equity and current DE&I challenges in the workplace.
Drug Topics
APRIL 26, 2023
The NexGard COMBO topical solution from Boehringer Ingelheim helps protect cats from tapeworms and other intestinal parasites like fleas, ticks, and heartworms.
STAT
APRIL 24, 2023
A new book on the U.S. response to the Covid-19 pandemic paints a picture of a country ill-prepared to cope with a dangerous biological foe, riven by partisan politics, and led by people who saw little political gain in taking ownership of managing the crisis. It also describes a country that remains ill-equipped to battle the next pandemic or major disease threat, though it lays out changes that could strengthen the country’s position.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PhRMA
APRIL 24, 2023
If we needed any more proof that the health insurance and pharmacy benefit manager (PBM) industries are one and the same, look no further than a new ad campaign by America’s Health Insurance Plans (AHIP). With PBMs facing increasing scrutiny on Capitol Hill, AHIP is hitting the airwaves to deflect any responsibility for the high cost of medicine many people face.
PharmaVoice
APRIL 24, 2023
Two decades after the Human Genome Project, scientists are on the brink of uncovering its full potential for drug development.
Drug Topics
APRIL 24, 2023
The Senate Finance Committee recently released a framework for legislation, and the leaders of the “big three” PBMs are scheduled to be witnesses at another committee's hearing regarding insulin prices on May 10.
Fierce Healthcare
APRIL 26, 2023
New AI-driven long COVID app coming soon to individual, enterprise customers agliadkovskaya Wed, 04/26/2023 - 14:04
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PhRMA
APRIL 24, 2023
Nonprofit hospitals are supposed to help provide access to crucial treatment and services in our most vulnerable communities. But recent research adds to the mountain of evidence showing nonprofit hospitals continue to fall short in their community benefit. For example, many nonprofit hospitals participate in the federal 340B Drug Pricing Program, where eligible large nonprofit hospitals can buy deeply discounted 340B medicines and then turn around and charge both uninsured patients and insuranc
PharmaVoice
APRIL 26, 2023
Drug developers have tried — and failed — to create a male contraceptive for decades. Now, one group of scientists might be on the verge of success.
Drug Topics
APRIL 24, 2023
Post-COVID-19 conditions were more common in unvaccinated children than in children who had received at least 1 dose of a COVID-19 vaccine.
Fierce Healthcare
APRIL 26, 2023
Kaiser Permanente to acquire Geisinger Health in bid to launch multi-system VBC platform dmuoio Wed, 04/26/2023 - 12:49
Fierce Pharma
APRIL 26, 2023
Eli Lilly's weight-loss drug passes 2nd trial with flying colors, setting up likely approval aliu Wed, 04/26/2023 - 22:30
Pharmacy Times
APRIL 28, 2023
Proposed rules would permit a telehealth provider to prescribe only up to a 30-day supply of a Schedule III-V non-narcotic controlled substance or buprenorphine through telehealth without the patient first being evaluated in person by a provider.
Drug Topics
APRIL 28, 2023
Prevnar 20 contains 20 serotypes and grants the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine.
Fierce Healthcare
APRIL 24, 2023
Home care industry touts bipartisan bill to expand Medicare in-home benefits, reimbursement dmuoio Mon, 04/24/2023 - 14:08
PharmaVoice
APRIL 28, 2023
Come November, Chris Boerner will take the top spot as the company approaches patent cliffs for three drugs in the next decade.
Pharmacy Times
APRIL 28, 2023
Prevnar 20 is a next-generation pneumococcal conjugate vaccine that includes capsular polysaccharide conjugates for the 13 serotypes already included in Prevnar 13.
Drug Topics
APRIL 27, 2023
The average annual healthcare spending for people with employer-sponsored insurance spending increased from $5,630 in 2020 to $6,467 in 2021. After decreasing in 2020, per person healthcare spending increased 15%.
Fierce Healthcare
APRIL 26, 2023
What gun violence costs U.S.
PharmaVoice
APRIL 27, 2023
Events over the last year, including Pfizer’s Seagen buy and AstraZeneca’s CinCor deal, have foreshadowed the comeback of biopharma M&A.
Pharmacy Times
APRIL 27, 2023
The analysis, published in Nature Communications, demonstrates glycan trimming also keeps the antibody response away from immunodominant glucan holes and patches.
Drug Topics
APRIL 28, 2023
The existing approach to disease management may be ill-suited to address the dynamic and diverse factors at play when it comes to chronic illness.
Let's personalize your content